oxophenylarsine has been researched along with Di Guglielmo Disease in 2 studies
oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu-Pong, S | 1 |
| Weiss, TL | 1 |
| Hunt, CA | 1 |
| Estrov, Z | 1 |
| Manna, SK | 1 |
| Harris, D | 1 |
| Van, Q | 1 |
| Estey, EH | 1 |
| Kantarjian, HM | 1 |
| Talpaz, M | 1 |
| Aggarwal, BB | 1 |
2 other studies available for oxophenylarsine and Di Guglielmo Disease
| Article | Year |
|---|---|
Calcium dependent cellular uptake of a c-myc antisense oligonucleotide.
Topics: Animals; Arsenicals; Base Sequence; Biological Transport; Calcium; Cell Line; Chloroquine; Deoxygluc | 1994 |
Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenicals; Caspase 3; Caspase Inhibitors; Cell Div | 1999 |